• 011-26907444
  • raghava@iiitd.ac.in

Welcome to Peptide Card of AntiTbPdb

This page displays user query in tabular form.

GF-G-Oic-GK-G-Oic-GF-G-Oic-GK-G-KKKK details
Primary information
ID antitb_1749,
NameUS 2012/0197004
N-Terminal modificationFKAB-1Gf1
C-Terminal ModificationGF-G-Oic-GK-G-Oic-GF-G-Oic-GK-G-KKKK
Chemical ModificationAcetylation
Linear/CyclicAmidation
LengthOic = Octahydroindolecarboxylic acid
ChiralityLinear
Nature19
SourceL
OriginHydrophobic
SpeciesSynthetic
Inhibition ConcentrationMycobacterium ranae
In Vitro/ In vivoMycobacterium ranae
Cell LineMIC = 100 μM
Inhibition ConcentrationBoth
Sequence2012
CytotoxicityRBC
In vivo ModelNA
Lethal Dose3.30 % hemolysis at 100 μM and 3.3 % at 25 μM
Immune ResponceMice
Mechanism of ActionNA
TargetNA
Combination TherapyNA
Other activitiesNA
PMIDNone
Year of PublicationAnti-bacterial (Salmonella typhimurium, Staphylococcus aureus, Bacillus subtillis)
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1790,
Name17547385
N-Terminal modificationPeptide-34
C-Terminal ModificationGF-G-Oic-GK-G-Oic-GF-G-Oic-GK-G-KKKK
Chemical ModificationAcetylation
Linear/CyclicAmidation
LengthOic = Octahydroindolecarboxylic acid
ChiralityLinear
Nature19
SourceL
OriginAmphipathic, Hydrophobic
SpeciesSynthetic
Inhibition ConcentrationMycobacterium ranae
In Vitro/ In vivoMycobacterium ranae (ATCC 110)
Cell LineMIC = 100 µM or 200 µg/mL
Inhibition ConcentrationBoth
Sequence2007
CytotoxicityRBC
In vivo ModelNA
Lethal Dose3.3 % and 3.30 % hemolytic activity at 100 µM and 25 µM peptide respectively
Immune ResponceNA
Mechanism of ActionNA
TargetStimulate innate immune system
Combination TherapyNA
Other activitiesNA
PMIDNA
Year of PublicationAntibacterial (Salmonella typhimurium (ATCC 13311), Staphylococcus aureus methicillin/gentamicin/tetrac+AB20ycline resistant (ATCC 33592), Bacillus subtillis (ATCC 43223))
Tertiary Structure
(Technique)
Not Predicted),